DBV Technologies (DBVT) Asset Utilization Ratio (2021 - 2026)
DBV Technologies (DBVT) posted Asset Utilization Ratio of 0.02 for Q2 2026, down 11.9% sequentially from 0.02 in Q1 2026, and down 49.42% YoY from 0.04 in Q2 2025.
Analysis
DBV Technologies (DBVT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
DBV Technologies has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.02 in Q2 2026.
- Quarterly Asset Utilization Ratio fell 49.42% year-over-year to 0.02 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.02 (down 49.42% YoY) and the FY2025 annual result came in at 0.04, up 11.46% from the prior year.
- Asset Utilization Ratio eased to 0.02 in Q2 2026 per DBVT's latest filing, from 0.02 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.12 in Q3 2024 and troughed at 0.02 in Q1 2023.
- A 5-year average of 0.05 and a median of 0.04 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 70.12% in 2023, then jumped 384.81% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.02 in 2022, then jumped by 330.78% to 0.08 in 2023, then slumped by 37.28% to 0.05 in 2024, then tumbled by 37.21% to 0.03 in 2025, then sank by 38.3% to 0.02 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.02, and 0.03 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 0.13 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.54 |
| 10 | DBV Technologies | 5.86 Bn | 5.69 Bn | - | 0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.02 |